Platelet support for cardiopulmonary bypass surgery.

Area of Science:

• Cardiovascular Surgery
• Hematology

Background:

• Fresh blood use for cardiopulmonary bypass (CPB) was discontinued.
• Platelet concentrates were routinely administered to patients post-CPB.
• The necessity of routine platelet concentrate administration was questioned.

Purpose of the Study:

• To determine if routine prophylactic platelet concentrate administration is necessary for patients undergoing cardiopulmonary bypass surgery.
• To compare platelet counts and hemostasis in patients receiving platelet concentrates versus those not receiving them.

Main Methods:

• A prospective study was conducted with 60 patients undergoing CPB.
• Patients were paired by procedure and age, receiving either 4 units of platelets (Group I) or no platelets (Group II).
• Platelet counts were monitored preoperatively, hourly during bypass, at multiple time points post-bypass, and daily for 7 days.

Main Results:

• No significant difference in mean platelet counts was observed between Group I and Group II at any time point.
• Total blood usage and post-bypass hemostasis time did not differ significantly between the groups.
• The degree of thrombocytopenia did not correlate with bypass time.

Conclusions:

• Prophylactic administration of platelet concentrates or fresh blood is not indicated for cardiopulmonary bypass surgery.
• Platelet use should be reserved for patients exhibiting thrombocytopenia with hemorrhagic complications.